Sho Sato

558 total citations
49 papers, 391 citations indexed

About

Sho Sato is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Sho Sato has authored 49 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 17 papers in Oncology. Recurrent topics in Sho Sato's work include Gastric Cancer Management and Outcomes (27 papers), Metastasis and carcinoma case studies (14 papers) and Esophageal Cancer Research and Treatment (9 papers). Sho Sato is often cited by papers focused on Gastric Cancer Management and Outcomes (27 papers), Metastasis and carcinoma case studies (14 papers) and Esophageal Cancer Research and Treatment (9 papers). Sho Sato collaborates with scholars based in Japan, United States and Italy. Sho Sato's co-authors include Itaru Endo, Hirotoshi Akiyama, Chikara Kunisaki, Kuniya Tanaka, Takashi Kosaka, Yusaku Tanaka, Kei Sato, Yukihiko Hiroshima, Norio Yukawa and Takashi Murakami and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgical Oncology.

In The Last Decade

Sho Sato

39 papers receiving 388 citations

Peers

Countries citing papers authored by Sho Sato

Since Specialization

Citations

This map shows the geographic impact of Sho Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Sato more than expected).

Fields of papers citing papers by Sho Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Sato. The network helps show where Sho Sato may publish in the future.

Co-authorship network of co-authors of Sho Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Sato. A scholar is included among the top collaborators of Sho Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Sato. Sho Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Indocyanine Green-Guided Lymphadenectomy During Gastrectomy on Survival: Individual Patient Data Meta-Analysis 2025 ·Cancers ·(unknown), Alberto Aiolfi, Sho Sato, (unknown), Gianluca Bonitta, (unknown), (unknown), Marta Cavalli, Giampiero Campanelli, Antonio Biondi, Luigi Bonavina, Davide Bona	1
2	Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study 2025 ·Anticancer Research ·(unknown), Tadahiro Shoji, Ami Jo, (unknown), (unknown), (unknown), (unknown), Sho Sato, (unknown), (unknown), Masahiro Kagabu, Fumiaki Takahashi, (unknown), Tsukasa Baba	0
3	Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors 2025 ·International Journal of Clinical Oncology ·Ami Jo, Tadahiro Shoji, (unknown), (unknown), (unknown), (unknown), Sho Sato, (unknown), (unknown), (unknown), Masahiro Kagabu, (unknown)	0
4	Prognostic factors in patients with pathological T3N0M0 gastric cancer: A multi-institutional, retrospective study (YCOG2202) 2024 ·European Journal of Surgical Oncology ·(unknown), Sho Sato, Chikara Kunisaki, Yusaku Tanaka, (unknown), Jun Kimura, Takashi Kosaka, Hidetaka Ono, Hirochika Makino, (unknown), Itaru Endo	0
5	Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601) 2023 ·Anticancer Research ·Sho Sato, (unknown), (unknown), (unknown), Kohei Kasahara, Tsutomu Sato, Hiroki Kondo, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo	0
6	Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer 2023 ·Anticancer Research ·Kohei Kasahara, (unknown), Sho Sato, Hiroki Kondo, (unknown), (unknown), Nobuhiro Tsuchiya, Yusaku Tanaka, Kei Sato, Jun Kimura, Takashi Kosaka, Hidetaka Ono, Hirochika Makino, Hirotoshi Akiyama, Itaru Endo	2
7	Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma 2022 ·Langenbeck s Archives of Surgery ·Nobuhiro Tsuchiya, Chikara Kunisaki, Sho Sato, Yusaku Tanaka, Kei Sato, Jun Watanabe, Kazuhisa Takeda, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo	2
8	Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer 2022 ·European Journal of Surgical Oncology ·Shinsuke Nagasawa, Tsutomu Sato, (unknown), (unknown), Nobuhiro Tsuchiya, Sho Sato, Kazuhisa Takeda, Toru Aoyama, Norio Yukawa, Yasushi Rino, Chikara Kunisaki	1
9	Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long‐term outcomes after gastrectomy 2021 ·Asia-Pacific Journal of Clinical Oncology ·(unknown), Takashi Kosaka, (unknown), Sho Sato, Hirotoshi Akiyama, Chikara Kunisaki, Itaru Endo	5
10	Feasibility of totally laparoscopic total gastrectomy in obese patients with gastric cancer 2021 ·Langenbeck s Archives of Surgery ·(unknown), Chikara Kunisaki, (unknown), Kei Sato, Sho Sato, Yusaku Tanaka, Norio Yukawa, Yasushi Rino, Takashi Kosaka, Itaru Endo, Munetaka Masuda	2
11	Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene–Deficient Mouse Model of Pancreatic Cancer 2020 ·Translational Oncology ·(unknown), Fumio Nakamura, Daiki Masukawa, Sho Sato, Yukihiko Hiroshima, Yasuhiro Yabushita, Rintaro Mori, Ryusei Matsuyama, Ikuma Kato, Hideki Taniguchi, Yoshio Goshima, Itaru Endo	4
12	Laparoscopic Total Gastrectomy for Gastric Cancer in Elderly Patients 2020 ·In Vivo ·(unknown), Chikara Kunisaki, (unknown), Kei Sato, Sho Sato, Yusaku Tanaka, Norio Yukawa, Yasushi Rino, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo, Munetaka Masuda	10
13	Efficacy of Video-assisted Thoracoscopic Esophagectomy for Stage II/III Esophageal Cancer: Analysis Using the Propensity Scoring System 2020 ·Anticancer Research ·(unknown), Chikara Kunisaki, Sho Sato, Yusaku Tanaka, Hiroshi Miyamoto, Takashi Kosaka, Kei Sato, Hirotoshi Akiyama, Itaru Endo, Norio Yukawa, Yasushi Rino, Munetaka Masuda, Takeharu Yamanaka	3
14	Systemic Review and Meta-analysis of Impact of Splenectomy for Advanced Gastric Cancer 2020 ·In Vivo ·Chikara Kunisaki, Sho Sato, Nobuhiro Tsuchiya, Jun Watanabe, Tsutomu Sato, Kazuhisa Takeda, Kohei Kasahara, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo, Toshihiro Misumi	2
15	Tumor Volume Index as a Prognostic Factor in Patients after Curative Esophageal Cancer Resection 2019 ·Annals of Surgical Oncology ·Hiroshi Miyamoto, Chikara Kunisaki, Sho Sato, Yusaku Tanaka, Kei Sato, Takashi Kosaka, Norio Yukawa, Hirotoshi Akiyama, Yusuke Saigusa, Itaru Endo	8
16	A Phase II Study of Tri-weekly Low-dose Nab-paclitaxel Chemotherapy for Patients with Advanced Gastric Cancer 2018 ·Anticancer Research ·Sho Sato, Chikara Kunisaki, Yusaku Tanaka, Kei Sato, Hiroshi Miyamoto, Norio Yukawa, Yoshiro Fujii, Jun Kimura, Ryo Takagawa, Masazumi Takahashi, Takashi Kosaka, Hirotoshi Akiyama, Yusuke Saigusa, Masataka Taguri, Takeharu Yamanaka, Itaru Endo	13
17	Evaluation of Optimal Lymph Node Dissection in Remnant Gastric Cancer Based on Initial Distal Gastrectomy 2018 ·Anticancer Research ·(unknown), Chikara Kunisaki, Sho Sato, Yusaku Tanaka, Hiroshi Miyamoto, Takashi Kosaka, Hirotoshi Akiyama, Itaru Endo, Yasushi Rino, Munetaka Masuda	5
18	A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer 2018 ·Anticancer Research ·Yusaku Tanaka, Chikara Kunisaki, (unknown), Hirochika Makino, Jun Kimura, Sho Sato, Hiroshi Miyamoto, Takashi Kosaka, Hidetaka Ono, Masazumi Takahashi, Kei Sato, Hirotoshi Akiyama, Itaru Endo	4
19	Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107 2017 ·Cancer Chemotherapy and Pharmacology ·Kei Sato, Chikara Kunisaki, Takashi Kosaka, Ryo Takagawa, Masazumi Takahashi, (unknown), Hiroshi Miyamoto, Sho Sato, Yusaku Tanaka, Naotaka Yamaguchi, Jun Kimura, Hidetaka Ono, Hirochika Makino, Hirotoshi Akiyama, Itaru Endo	2
20	Clinical study of testicular germ cell tumors. 2001 ·PubMed ·Hiroshi Tomomasa, Hiroshi Shimizu, Sho Sato, (unknown), (unknown), Yoichi Kamiyama, (unknown), Masami Sato, Takeharu Yoshii, Takashi Iizumi, T. Umeda, Tsunetada Yazaki	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact